SMS Pharmaceuticals Ltd — Share Issue/Capital Change 2025

Nov 7, 2025

Date: 7 th November, 2025

To The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Security Code: 532815

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051. Symbol: SMSPHARMA

Dear Sir/Madam,

Sub: Intimation of Listing & Trading approval received from BSE Limited and National Stock Exchange of India Limited (NSE) for 50,00,000 equity shares of Rs. 1/- each issued at a premium of Rs.126/- to Promoters/promoters group on a preferential basis pursuant to conversion of warrants

We would like to inform you that the Company has received Trading approval for 50,00,000 Equity shares of Re. 1/- each allotted pursuant to conversion of warrants issued on preferential basis from BSE Limited and National Stock Exchange of India Limited (NSE) and the above mentioned equity shares are listed and admitted to dealings on the Exchanges with effect from Friday, November 07, 2025.

The approval Letters received from BSE Limited and NSE are enclosed herewith.

We request you to take the above information on record.

Thanking you

Yours Faithfully For SMS Pharmaceuticals Limited

THIRUMALE SH TUMMA Digitally signed by THIRUMALESH TUMMA Date: 2025.11.07 15:21:57 +05'30'

Thirumalesh Tumma Company Secretary

LOD / PREF / SV / 8/ 2025-2026 " E - Letter " Thursday, November 06, 2025

The Company Secretary SMS Pharmaceuticals Ltd Plot. No; 72, H, H. No; 8-2-334/3&4, Road. No: 5,, Banjara Hills,, , Hyderabad, Telangana, 500034

Dear Sir / Madam,

Re: Trading of 50,00,000 Equity Shares of Re. 1/- each to be issued at a premium of Rs. 126/bearing distinctive numbers from 88652031 to 93652030 issued to Promoters on a preferential basis pursuant to conversion of warrants.

We acknowledge with thanks the receipt of your application and subsequent submissions and have pleasure in advising that effective from Friday, November 7, 2025. In the above-mentioned securities are listed on the Exchange.

Please refer our Notice No. 20251106-26 dated November 06, 2025 available on our website issued in this behalf to the Trading Members of the Exchange, for your information, the contents of which may please be checked and confirmed to the Exchange.

Yours faithfully,

$Sd$ . Kinnar Mehta Assistant Vice President

$Sd$ /-Prachi Babadi Manager

BSE Limited (Formerly Bombay Stock Exchange Ltd.)
Registered Office : Floor 25, P J Towers, Dalal Street, Mumbai 400 001 India
T: +91 22 2272 1234/33 |
Corporate Identity Numl | PUBLIC | #2005PLC155188

Sub: Listing of further issue under Preferential

Ref.: NSE/LIST/ 51626					November 06, 2025
	The Company Secretary SMS Pharmaceuticals Limited Plot No. 72, H.No. 8-2-334/3&4, Road No.5 Opp. SBI Executive enclave Banjara Hills Hyderabad Hyderabad-500034.
	Dear Sir/Madam,
		Sub: Listing of further issue under Preferential
	This is with reference to the application for the listing of further issue of 5000000 Equity shares of Re. 1/- each allotted pursuant to conversion of warrants issued on preferential basis made by the company. We are pleased to inform you that the above equity shares of the Company are listed and admitted to dealings on the Exchange from November 07, 2025 as per the details given below:
Sr. No.	Security Description	Symbol	Series	No. of securities	Distinctive Numbers	Date upto which lock in
1.	Equity shares of Re. 1/- each allotted pursuant to conversion of warrants issued on preferential basis	SMSPHARMA	EQ	5000000	88652031 to 93652030	30-Oct-2027
	Please note that all critical/price sensitive information and other submissions under Securities and

Please note that all critical/price sensitive information and other submissions under Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 shall be NSE Electronic Application Processing System (https://neaps.nseindia.com/NEWLISTINGCORP/) , an online filing facility provided by the Exchange, for quicker and efficient processing of your submissions. CC: National Securities Depository Limited Lower Parel, Mumbai - 400 013

If you require any further clarifications, we shall be glad to oblige.

Yours faithfully, For National Stock Exchange of India Limited

Srishti Soni

Manager

4th Floor, Trade world, Kamala Mills Compound, Senapati Bapat Marg.,

Central Depository Services Limited Marathon Futurex, A-Wing, 25th floor, N M Joshi Marg, Lower Parel, Mumbai 400 013

P.S. Checklist of all the further issues is available on website of the exchange at the following URL: https://www.nseindia.com/companies-listing/raising-capital-further-issues-main-sme-checklist